AMANDA FRITZ: Open Payments
NPI 1720358989 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$682 in 24 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $682
Food & beverage: $484Education: $198
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $184 |
| Merck Sharp & Dohme LLC | 4 | $76 |
| Janssen Biotech, Inc. | 2 | $61 |
| ABBVIE INC. | 2 | $55 |
| Aveo Pharmaceuticals, Inc. | 2 | $43 |
| JAZZ PHARMACEUTICALS INC. | 1 | $39 |
| PharmaEssentia USA Corporation | 1 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Eisai Inc. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
Products named: FOTIVDA, ZIIHERA, ERLEADA, BESREMI, KEYTRUDA, EMRELIS, Lenvima, ORGOVYX.
Industry payments across WI — which companies pay providers there.
